Rheo-Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial
- Maria Kjølhede(corresponding author),
- Grethe Andersen,
- Jan Brink Valentin,
- Marlene Christina Nielsen,
- Morten Nørgaard Andersen,
- Aarhus University,
- Aalborg University,
- University Clinic in Nephrology and Hypertension,
Scholary Output:
Contribution to journal
Letter
Peer-review
Open access
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Article number
e031466Journal (Volume, Issue Number)
Journal of the American Heart Association (Volume 12, Issue 22)Publication milestones
- Published - 11/21/2023
Publication status
Published - 11/21/2023
ISSN
2047-9980Publication IDs
- Scopus: 85178883797
- PubMed: 37947084
- ORCID: /0000-0001-8231-1256/work/157546455
Publication metrics
Metrics
Fractional count
2
Fractional count
0.22
Fractional count
7
Fractional count
0.78
Fractional count
2
Fractional count
1
PlumX, opens in new tab
Social media
40
Captures
10
Citation count
5
Funding Details
The trial received funding from the Novo Nordisk Foundation and the Lundbeck Foundation.
FundersFunding numbers
Lundbeck Foundation Initiative for Integrative Psychiatric Research
-NNF
-